✦ LIBER ✦
704 A Phase 1 Open-Label, Single-Dose, Dose-Escalation Study of Mdx-1100, a High-Affinity, Neutralizing, Fully Human Igg1κ Anti-CXCL10 (Ip10) Monoclonal Antibody, in Ulcerative Colitis
✍ Scribed by Robert Hardi; Lloyd Mayer; Stephan R. Targan; Michael Yellin; Pina M. Cardarelli; Kiron M. Das
- Book ID
- 119428341
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 185 KB
- Volume
- 134
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.